These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
4. [Recurrence of the initial disease after liver transplantation]. Dousset B; Calmus Y; Merrigi F; Houssin D Gastroenterol Clin Biol; 1989 Dec; 13(12):984-96. PubMed ID: 2560439 [No Abstract] [Full Text] [Related]
5. Recommendations for outpatient monitoring of kidney transplant recipients. Hariharan S Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S22-36. PubMed ID: 16567238 [TBL] [Abstract][Full Text] [Related]
6. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J Circulation; 2004 Dec; 110(24):3734-40. PubMed ID: 15596559 [No Abstract] [Full Text] [Related]
7. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965 [TBL] [Abstract][Full Text] [Related]
8. [The transplant patient at the community health center and the emergency department]. Westman K; Castedal M; Bennet W; Kornhall B Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1762-5. PubMed ID: 23097886 [No Abstract] [Full Text] [Related]
9. Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection. Platz KP; Mueller AR; Haller GW; Naumann U; Berg T; Fukomoto T; Lemmens HP; Hopf U; Lobeck H; Neuhaus P Transplant Proc; 1996 Dec; 28(6):3236-7. PubMed ID: 8962252 [No Abstract] [Full Text] [Related]
11. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral. Levy GA Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216 [No Abstract] [Full Text] [Related]
12. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259 [TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339 [TBL] [Abstract][Full Text] [Related]
14. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Charlton M; Seaberg E Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024 [TBL] [Abstract][Full Text] [Related]
15. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Jiménez-Rivera C; Avitzur Y; Fecteau AH; Jones N; Grant D; Ng VL Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961 [TBL] [Abstract][Full Text] [Related]
17. [Immunosuppression in hand transplantation: state of the art and future perspectives]. Sucher R; Hautz T; Brandacher G; Lee WP; Margreiter R; Schneeberger S Handchir Mikrochir Plast Chir; 2009 Aug; 41(4):217-23. PubMed ID: 19688652 [TBL] [Abstract][Full Text] [Related]
18. [Polyomavirus and tubulointerstitial nephropathy]. Antoine C; Hill G; Glotz D; Fontanière B; Tabone E; Nochy D Nephrologie; 2001; 22(6):317-20. PubMed ID: 11715610 [No Abstract] [Full Text] [Related]
19. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
20. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]